Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 06, 2023 07:00 ET | Source: Ractigen Therapeutics

Ractigen Therapeutics Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01

This milestone marks Ractigen's transition into clinical development, with RAG-01 targeting NMIBC.
November 02, 2023 08:00 ET | Source: Ractigen Therapeutics

Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting

Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
January 09, 2023 07:00 ET | Source: Ractigen Therapeutics

Ractigen Therapeutics Announces the Appointment of Harri Järveläinen as Chief Operating Officer

SUZHOU, China, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Ractigen Therapeutics, Inc. announced today that Dr. Harri Järveläinen has been appointed Chief Operating Officer of the Company. "I am thrilled to...